Fresenius Medical Care AG
FMEA
Company Profile
Business description
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Contact
Else-Kroner-Strasse 1
Bad HomburgHE61352
DEUT: +49 15114965619
E: robert.adolph(at)fmc-ag.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2025
Employees
109,916
Stocks News & Analysis
stocks
Progress in UK expansion for undervalued ASX share
Guidance reaffirmed and UK implementation on track.
stocks
The sectors set to soar on government spending
Governments worldwide love to spend more money, and there are no signs that it will change any time soon.
stocks
Chart of the Week: How private companies are reshaping public markets
Our latest take from the US Manager Research team.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,098.60 | 9.70 | -0.11% |
| CAC 40 | 8,009.80 | 64.43 | -0.80% |
| DAX 40 | 23,966.99 | 82.75 | -0.34% |
| Dow JONES (US) | 47,320.00 | 9.00 | 0.02% |
| FTSE 100 | 9,766.77 | 10.31 | -0.11% |
| HKSE | 26,485.90 | 550.49 | 2.12% |
| NASDAQ | 23,443.86 | 55.94 | -0.24% |
| Nikkei 225 | 50,883.68 | 671.41 | 1.34% |
| NZX 50 Index | 13,576.81 | 44.17 | -0.32% |
| S&P 500 | 6,792.30 | 3.99 | -0.06% |
| S&P/ASX 200 | 8,828.30 | 8.50 | -0.10% |
| SSE Composite Index | 4,007.76 | 38.51 | 0.97% |